BioCentury | Oct 12, 2015
Financial News

Immune Pharmaceuticals completes private placement of convertible preferred stock

...316 Shares outstanding prior: 27.1 million Placement agents: Chardan Capital Markets; Roth Capital Partners Investor: Discover Growth Fund...
BioCentury | Aug 3, 2015
Financial News

Immune Pharmaceuticals completes private placement of convertible preferred stock

...947 Shares outstanding prior: 27.1 million Placement Agents: Chardan Capital Markets; Roth Capital Partners Investor: Discover Growth Fund...
BioCentury | May 4, 2015
Financial News

Amarantus BioScience completes private placement of convertible preferred stock

...of convertible preferred stock Raised: $5 million Shares: 1,087 Shares outstanding prior: 1 billion Investor: Discover Growth Fund...
Items per page:
1 - 3 of 3
BioCentury | Oct 12, 2015
Financial News

Immune Pharmaceuticals completes private placement of convertible preferred stock

...316 Shares outstanding prior: 27.1 million Placement agents: Chardan Capital Markets; Roth Capital Partners Investor: Discover Growth Fund...
BioCentury | Aug 3, 2015
Financial News

Immune Pharmaceuticals completes private placement of convertible preferred stock

...947 Shares outstanding prior: 27.1 million Placement Agents: Chardan Capital Markets; Roth Capital Partners Investor: Discover Growth Fund...
BioCentury | May 4, 2015
Financial News

Amarantus BioScience completes private placement of convertible preferred stock

...of convertible preferred stock Raised: $5 million Shares: 1,087 Shares outstanding prior: 1 billion Investor: Discover Growth Fund...
Items per page:
1 - 3 of 3